IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 359 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $7,500 | +6.7% | 150 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $7,028 | +11.1% | 150 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $6,328 | +13.7% | 150 | 0.0% | 0.00% | +33.3% |
| Q1 2023 | $5,567 | -0.2% | 150 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $5,579 | -7.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $6,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $6,000 | +20.0% | 150 | 0.0% | 0.00% | +33.3% |
| Q1 2022 | $5,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $5,000 | 0.0% | 150 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $5,000 | -16.7% | 150 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $6,000 | -14.3% | 150 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $7,000 | -22.2% | 150 | 0.0% | 0.01% | -33.3% |
| Q4 2020 | $9,000 | +28.6% | 150 | 0.0% | 0.01% | +12.5% |
| Q3 2020 | $7,000 | -22.2% | 150 | 0.0% | 0.01% | -20.0% |
| Q2 2020 | $9,000 | +12.5% | 150 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $8,000 | -11.1% | 150 | 0.0% | 0.01% | +11.1% |
| Q4 2019 | $9,000 | – | 150 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |